Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

SIMPLE, DIRECT AND INFORMATIVE METHOD FOR THE ASSESSMENT OF CYP2C19 ENZYME INACTIVATION KINETICS

Kaisa A Salminen, Jukka Leppanen, Jarkko I Venalainen, Markku Pasanen, Seppo Auriola, Risto O Juvonen and Hannu Raunio
Drug Metabolism and Disposition December 9, 2010, dmd.110.036376; DOI: https://doi.org/10.1124/dmd.110.036376
Kaisa A Salminen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kaisa.salminen@uef.fi
Jukka Leppanen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jarkko I Venalainen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markku Pasanen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seppo Auriola
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Risto O Juvonen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hannu Raunio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

dmd.110.036376
DOI 
https://doi.org/10.1124/dmd.110.036376
PubMed 
21148250

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received September 23, 2010
  • Accepted December 9, 2010
  • Published online December 9, 2010.

Article Versions

  • You are currently viewing an Earlier version of this article (December 9, 2010 - 06:33).
  • View the most recent version of this article
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Kaisa A Salminen1,3,
  2. Jukka Leppanen1,
  3. Jarkko I Venalainen2,
  4. Markku Pasanen1,
  5. Seppo Auriola1,
  6. Risto O Juvonen1 and
  7. Hannu Raunio1
  1. 1 School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland;
  2. 2 Orion Corporation, ORION PHARMA, Research and Development, Turku, Finland
  1. 3 E-mail: kaisa.salminen{at}uef.fi

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 20170114
Sep 20170128
Oct 20170225
Nov 20173298
Dec 20171207
Jan 20180207
Feb 20180243
Mar 20180214
Apr 20180274
May 20180205
Jun 20180294
Jul 201801015
Aug 20181158
Sep 20180112
Oct 2018287
Nov 20182915
Dec 2018643
Jan 2019522
Feb 20192033
Mar 20191210
Apr 20192805
May 20191714
Jun 2019805
Jul 20191123
Aug 20191613
Oct 20192000
Nov 20192202
Dec 20191612
Jan 20201123
Feb 2020821
Mar 20201533
May 20201510
Jun 20201100
Jul 20201801
Aug 2020704
Sep 20202134
Oct 2020933
Nov 2020701
Dec 2020413
Jan 20211956
Feb 20211656
Mar 20211324
Apr 20211921
May 20212721
Jun 20211232
Jul 20211335
Aug 2021445
Sep 20211713
Oct 20214311
Nov 20211214
Dec 20211223
Jan 20221014
Feb 2022914
Mar 20221142
Apr 2022522
May 20221610
Jun 20224621
Jul 202213717
Aug 20222138
Sep 20221621
Oct 20222545
Nov 20222088
Dec 2022927
Jan 20233130
Feb 20231124
Mar 2023911

Next
Back to top

In this issue

Drug Metabolism and Disposition: 51 (4)
Drug Metabolism and Disposition
Vol. 51, Issue 4
1 Apr 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
SIMPLE, DIRECT AND INFORMATIVE METHOD FOR THE ASSESSMENT OF CYP2C19 ENZYME INACTIVATION KINETICS
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

SIMPLE, DIRECT AND INFORMATIVE METHOD FOR THE ASSESSMENT OF CYP2C19 ENZYME INACTIVATION KINETICS

Kaisa A Salminen, Jukka Leppanen, Jarkko I Venalainen, Markku Pasanen, Seppo Auriola, Risto O Juvonen and Hannu Raunio
Drug Metabolism and Disposition December 9, 2010, dmd.110.036376; DOI: https://doi.org/10.1124/dmd.110.036376

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

SIMPLE, DIRECT AND INFORMATIVE METHOD FOR THE ASSESSMENT OF CYP2C19 ENZYME INACTIVATION KINETICS

Kaisa A Salminen, Jukka Leppanen, Jarkko I Venalainen, Markku Pasanen, Seppo Auriola, Risto O Juvonen and Hannu Raunio
Drug Metabolism and Disposition December 9, 2010, dmd.110.036376; DOI: https://doi.org/10.1124/dmd.110.036376
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A PBPK model for CBD in adults and children
  • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
  • Absorption, Metabolism, and Excretion of Taselisib
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics